FDA recall D-0235-2022

Product

Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04

Reason for recall

Failed Impurities/Degradation Specifications

Distribution

Nationwide and Puerto Rico

Key facts

Status

Terminated

Initiation date

2021-10-28

Report date

2021-11-24

Termination date

2023-02-27

Voluntary/Mandated

Voluntary: Firm initiated

Location

Parsippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0235-2022